menu
    • menu
    [{"orgOrder":0,"company":"Link Immunotherapeutics","sponsor":"Context Therapeutics","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"U.S.A","productType":"Large molecule","year":"2024","type":"Acquisition","leadProduct":"CT-95","moa":"","graph1":"Oncology","graph2":"IND Enabling","graph3":"Link Immunotherapeutics","amount2":0,"highestDevelopmentShortName":"IND","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"","sponsorNew":"Link Immunotherapeutics \/ Context Therapeutics","highestDevelopmentStatusID":"5","companyTruncated":"Link Immunotherapeutics \/ Context Therapeutics"}]

    Find Clinical Drug Pipeline Developments & Deals by Link Immunotherapeutics

    Menu

    Link Immunotherapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Link Immunotherapeutics

                            U.S.A arrow
                            PharmaVenue
                            Not Confirmed

                            Link Immunotherapeutics

                            U.S.A arrow
                            PharmaVenue
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : CT-95

                            Therapeutic Area : Oncology

                            Study Phase : IND Enabling

                            Sponsor : Context Therapeutics

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

                            Details : Context Therapeutics acquires CT-95, a potential first-in-class mesothelin x CD3 bispecific antibody, which is ready Phase 1-ready T cell Engager for the treatment of solid tumors.

                            Brand Name : CT-95

                            Molecule Type : Large molecule

                            Upfront Cash : Undisclosed

                            July 10, 2024

                            Lead Product(s) : CT-95

                            Therapeutic Area : Oncology

                            Highest Development Status : IND Enabling

                            Sponsor : Context Therapeutics

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth